Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax and Romidepsin in Relapsed/Refractory Mature T-Cell Lymphomas
NCT03534180Phase 2Completed
- Sponsor
- City of Hope
- Start
- Sep 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax, romidepsin in mature T-cell lymphoma (PTCL), sponsored by City of Hope. Started Sep 2018; status: completed.
02
Drugs
venetoclaxromidepsin
03
Conditions
mature T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03534180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534180.